Medtronic - MITG
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Medtronic - MITG sits in the top decile of US sponsors by registered trial count (#218 of 15,742 sponsors by registered trial count).
Medtronic - MITG: 119 sponsored US clinical trials, 5 recruiting.
Medtronic - MITG sponsors 119 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 99 completed. 5 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypoxia, with 3 trials.
Top-decile sponsor footprint
Medtronic - MITG ranks in the top decile of sponsors by registered trial count (#218 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
99 of 109 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
119 total, page 1 of 3
Solv Multi-Pass Hemodialysis System In-Center Clinical Study
NCT07216885
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
NCT07351071
Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)
NCT07120945
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
NCT06710795
Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding
NCT06188585
Accuracy Verification of the INVOS PM7100
NCT07166341
Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia
NCT06449378
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Hernia Surgery (Enable Hernia Repair)
NCT06445504
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
NCT05696444
Prospective, Multi-center, Single-arm, Observational Study. US FDA 522 Pediatric Post Market Surveillance Study.
NCT04608149
Nellcor™ Abbreviated Sensor Additional Data Collection
NCT07201961
Philips FAST Evaluation
NCT06860230
OM2 Low Saturation Verification
NCT06661889
Accuracy Performance Verification of the INVOS™ PM7100 System in Adults
NCT06581835
Pulse Oximetry Performance Comparison in Newborns
NCT06637917
Perfusion Index Parameter
NCT06586918
OM2 Motion Verification Study
NCT06415786
OM2 Abbreviated Sensor Verification
NCT06415799
Accuracy Performance Verification of the INVOS™ System in Pediatrics
NCT05962905
N600X Low Saturation Accuracy Validation
NCT05532670
Bispectral Index and End-Tidal Anesthetic Gas Concentration in Pediatric Patients
NCT04810481
SpO2 Accuracy Low Saturation Validation of the OxySoftN Sensor
NCT04811963
Evaluation of Bispectral Index (BIS™) and Levels of Sedation With Common Inhalational Anesthetics in Healthy Volunteers (OLIVER)
NCT04602546
SpO2 Accuracy Validation of the OxySoft Sensor Via Reference CO-Oximetry Motion Study
NCT04559763
Bispectral Index and Levels of Sedation With Propofol With/Without Remifentanil in Healthy Volunteers (SONORA)
NCT04466384
A Post Market Study to Confirm the Safety and Performance of the Signia™ Stapling System.
NCT03515811
Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)
NCT03771508
A Study of BiZact™ on Children and Adolescents Undergoing Tonsillectomy
NCT03266094
superDimension™ Navigation System Version 7.2 With Fluoroscopic Navigation Technology
NCT03585959
Trending of Respiratory Rate Using the Nellcor™ Bedside Respiratory Patient Monitoring System
NCT03593603
Post Market Study of Parietene™ DS Composite Mesh in Ventral Hernia Repair
NCT03495154
A Comparison of Capnography Sampling Lines
NCT03554629
Post Market Clinical Follow Up Study for ReliaTack™ Articulating Reloadable Fixation Device With Deep Purchase Tacks
NCT03526341
Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease.
NCT03241368
Validation of Next Generation Cerebral and Tissue Oximeter
NCT03128372
PRediction of Opioid-induced Respiratory Depression In Patients Monitored by capnoGraphY
NCT02811302
Surveillance Monitoring as an Alternative to Telemetry
NCT03039738
Determination of the Clinical Impact of Continuous Surveillance Monitoring (SM) and Utility of IPI.
NCT03050983
A Study of BiZact™ on Adults Undergoing Tonsillectomy
NCT02876575
Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
NCT02754661
Impact of Neuromonitoring During Cardiac Procedures
NCT02681731
Clinical Utility of Capnography in the PACU( Post-anaesthesia Care Unit)
NCT02707003
Performance Assessment of a Remote Patient Monitoring Device
NCT02570906
Cytosponge Adequacy Study Evaluation II
NCT02395471
Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure
NCT02481219
NAVIGATE: Clinical Evaluation of superDimension™ Navigation System for Electromagnetic Navigation Bronchoscopy™
NCT02410837
Case Series to Evaluate the Identification of Anatomical Markers Using the KANGAROO™ Feeding Tube
NCT02430571
The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS)
NCT02323854
A Prospective, Multi-center, Single-arm Study of the Stomach, Intestinal and Pylorus Sparing (SIPS) Procedure
NCT02275208
Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion
NCT02247765
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 4 |
What is open in the Medtronic - MITG pipeline
5 recruiting of 119 indexed (4% open); 99 completed (83%).
Phase mix: 5 late (III/IV) vs 5 early (I/II) (balanced across stages).
Top condition: Hypoxia (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medtronic - MITG: open-pipeline peers nationwide
Peers matched on 119 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
Medtronic - MITG sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 119 trials (± recruiting share)
- Children's Hospital Los Angeles · 119 trials · 29% recruiting
- Jaeb Center for Health Research · 119 trials · 14% recruiting
- Michigan State University · 120 trials · 20% recruiting
- San Diego State University · 118 trials · 27% recruiting
Sponsors near 4% open enrollment (± trial volume)
- National Institute on Drug Abuse (NIDA) · 4% recruiting · 335 trials
- Akebia Therapeutics · 4% recruiting · 24 trials
- Dentsply Sirona Implants and Consumables · 4% recruiting · 24 trials
- Smith & Nephew · 4% recruiting · 72 trials
Related
What to do with this Medtronic - MITG page
119 registered trials is a research-attention snapshot, not an endorsement of Medtronic - MITG or any single study.
- 5 of Medtronic - MITG's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypoxia is the condition Medtronic - MITG studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypoxia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medtronic - MITG pipeline card: 119 registered trials from official public datasets.Report a data error.